Lynne Krummen
Corporate Officer/Principal chez VIR BIOTECHNOLOGY, INC.
Profil
Lynne Krummen is currently working as the Executive VP-Product Development at Vir Biotechnology, Inc. She started this position in 2023.
Prior to her current role, she worked at Genentech, Inc. as the VP & Global Head-Biologics, Regulatory CMC from 2011 to 2018.
Dr. Krummen holds a doctorate degree from The University of Cincinnati College of Medicine.
Postes actifs de Lynne Krummen
Sociétés | Poste | Début |
---|---|---|
VIR BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01/10/2023 |
Anciens postes connus de Lynne Krummen
Sociétés | Poste | Fin |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Formation de Lynne Krummen
The University of Cincinnati College of Medicine | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
VIR BIOTECHNOLOGY, INC. | Health Technology |
Entreprise privées | 1 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |